Furthermore, proteomic analyses showed that combined treatment of Jia Wei BZYQ decoction and routine western medicines resulted in abnormal expression of some proteins including myosin heavy chain 9 (MYH9), filamin A (FLNA), tubulin alpha-4A (TUBA4A), thrombospondin-1 (THBS1), tropomyosin alpha-4 (TPM4), Ras suppressor protein 1 (RSU1), ACTN1, and PPBP compared with healthy control group, untreated group, and routine treatment group, indicating that Jia Wei BZYQ decoction might exert its therapeutic effects for MG by regulating these proteins (Table 7). This evidence concerns the gene RSU1 and myasthenia gravis.